NHLBI SBIR Phase IIB Bridge Awards
Supports small businesses advancing NHLBI discoveries toward regulatory clearance milestones.
The NHLBI SBIR Phase IIB Bridge Awards program provides late-stage, non-dilutive R&D funding to US small businesses seeking to advance heart, lung, blood, and sleep disorder technologies toward regulatory clearance and commercialization. The governing FOA is RFA-HL-26-014, a reissue of RFA-HL-23-009, which was released November 18, 2024. The FOA was marked expired per NOT-OD-26-006 with an updated…
Late-stage development of heart, lung, blood, and sleep disorder technologies toward regulatory clearance; limited to small businesses continuing prior NHLBI-funded SBIR or STTR Phase II work.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline
Guides for this application
All guides →SBIR/STTR Grants for Deeptech Startups
A practical guide to SBIR and STTR grants for deeptech startups, including agency fit, Phase I and II logic, eligibility, budgets, and review criteria.
DocumentsNIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
More from NHLBI
All grants from this funder →NHLBI SBIR/STTR — Standard
🇺🇸NHLBI · United States
Supports small businesses advancing heart, lung, blood, and sleep-related technologies through NHLBI.
NHLBI Catalyze — Reissue
🇺🇸NHLBI · United States
Supports NHLBI translational pathways toward first-in-human feasibility testing.
NHLBI Small Grant Program for K Recipients
🇺🇸NHLBI · United States
Supports former K awardees moving to independent NHLBI research through small grants.
Similar grants
Browse the directory →
NIH SBIR Phase II
🇺🇸NIH SEED · United States
Supports United States biomedical small businesses advancing successful feasibility work into scale-up development.
NIEHS SBIR Phase II
🇺🇸NIEHS · United States
Supports United States. small businesses scaling environmental health technologies toward full development.
NCATS STTR Phase II
🇺🇸NCATS · United States
Funds U.S. small businesses and their nonprofit research partners to continue and expand translational R&D begun in STTR Phase I toward a commercial product.
NCI SBIR/STTR Omnibus (Next Receipt 5)
🇺🇸NCI · United States
Supports small businesses developing cancer technologies through national NIH collaboration pathways.
ART — NSF 25-548
🇺🇸NSF TIP · United States
Supports university infrastructure growth in technology transfer through NSF research grants.
NIH CRP Commercialization Readiness Pilot
🇺🇸NIH SEED · United States
Offers late stage commercialization readiness support through NIH CRP for small firms advancing biomedical health solutions.